Skip to main content
. 2016 Apr 21;2016(4):CD000543. doi: 10.1002/14651858.CD000543.pub4

Comparison 2. 5‐ASA versus sulfasalazine.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Failure to Induce Global/Clinical Remission 8 526 Risk Ratio (M‐H, Fixed, 95% CI) 0.90 [0.77, 1.04]
1.1 5‐ASA / SASP <1/2 1 29 Risk Ratio (M‐H, Fixed, 95% CI) 0.9 [0.57, 1.41]
1.2 1/1 > 5‐ASA / SASP >or= 1/2 5 359 Risk Ratio (M‐H, Fixed, 95% CI) 0.91 [0.77, 1.08]
1.3 5‐ASA / SASP >or= 1/1 3 138 Risk Ratio (M‐H, Fixed, 95% CI) 0.85 [0.59, 1.23]
2 Failure to Induce Global/Clinical Remission or Improvement 14 1053 Risk Ratio (M‐H, Fixed, 95% CI) 0.88 [0.76, 1.01]
2.1 5‐ASA / SASP <1/2 3 123 Risk Ratio (M‐H, Fixed, 95% CI) 0.77 [0.47, 1.27]
2.2 1/1 > 5‐ASA / SASP >or= 1/2 11 804 Risk Ratio (M‐H, Fixed, 95% CI) 0.90 [0.77, 1.05]
2.3 5‐ASA / SASP >or= 1/1 3 126 Risk Ratio (M‐H, Fixed, 95% CI) 0.81 [0.54, 1.22]
3 Failure to Induce Endoscopic Remission 2   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
3.1 5‐ASA / SASP <1/2 0   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 1/1 > 5‐ASA / SASP >or= 1/2 2   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 5‐ASA / SASP >or= 1/1 0   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Failure to Induce Endoscopic Remission or Improvement 6 362 Risk Ratio (M‐H, Fixed, 95% CI) 0.82 [0.65, 1.02]
4.1 5‐ASA / SASP <1/2 1 29 Risk Ratio (M‐H, Fixed, 95% CI) 0.78 [0.58, 1.04]
4.2 1/1 > 5‐ASA / SASP >or= 1/2 4 246 Risk Ratio (M‐H, Fixed, 95% CI) 0.73 [0.53, 1.02]
4.3 5‐ASA / SASP >or= 1/1 2 87 Risk Ratio (M‐H, Fixed, 95% CI) 1.06 [0.72, 1.57]
5 Development of Any Adverse Event 12 909 Risk Ratio (M‐H, Fixed, 95% CI) 0.48 [0.36, 0.63]
5.1 5‐ASA / SASP <1/2 1 56 Risk Ratio (M‐H, Fixed, 95% CI) 0.35 [0.10, 1.20]
5.2 1/1 > 5‐ASA / SASP >or= 1/2 9 746 Risk Ratio (M‐H, Fixed, 95% CI) 0.55 [0.41, 0.73]
5.3 5‐ASA / SASP >or= 1/1 2 107 Risk Ratio (M‐H, Fixed, 95% CI) 0.16 [0.05, 0.52]
6 Withdrawal from Study due to Adverse Event 10 640 Risk Ratio (M‐H, Fixed, 95% CI) 0.40 [0.24, 0.68]
6.1 5‐ASA / SASP <1/2 2 85 Risk Ratio (M‐H, Fixed, 95% CI) 0.16 [0.02, 1.41]
6.2 1/1 > 5‐ASA / SASP >or= 1/2 5 361 Risk Ratio (M‐H, Fixed, 95% CI) 0.67 [0.32, 1.39]
6.3 5‐ASA / SASP >or= 1/1 4 194 Risk Ratio (M‐H, Fixed, 95% CI) 0.25 [0.10, 0.60]
7 Exclusions and Withdrawals after Entry 10 701 Risk Ratio (M‐H, Fixed, 95% CI) 0.76 [0.58, 0.99]
7.1 5‐ASA / SASP <1/2 1 29 Risk Ratio (M‐H, Fixed, 95% CI) 0.10 [0.01, 1.80]
7.2 1/1 > 5‐ASA / SASP >or= 1/2 6 478 Risk Ratio (M‐H, Fixed, 95% CI) 0.97 [0.71, 1.34]
7.3 5‐ASA / SASP >or= 1/1 4 194 Risk Ratio (M‐H, Fixed, 95% CI) 0.44 [0.25, 0.77]